Skip to content

GRAIL, Inc. GRAL Cash ratio

Cash ratio at other companies

Abbott logo
AbbottABT
0.4×-0.1×
Guardant Health logo
Guardant HealthGH
3.8×+0.2×
Natera, Inc. logo
Natera, Inc.NTRA
1.9×-0.7×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
1.7×+1.2×
Immunome logo
ImmunomeIMNM
21.3×+12.9×
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
0.9×+0.3×

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

Based on the most recent quarter.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s cash ratio?
GRAIL, Inc. (GRAL) reported cash ratio of 1× in Q1 2026.
How has GRAIL, Inc.'s cash ratio changed year-over-year?
GRAIL, Inc.'s cash ratio decreased by 44.2% year-over-year, from 1.8× to 1×.
What is the long-term trend for GRAIL, Inc.'s cash ratio?
Over 2 years (2023 to 2025), GRAIL, Inc.'s cash ratio has grown at a 127.9% compound annual growth rate (CAGR), from 0.6× to 3.2×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.